Lingfeng You

629 total citations
17 papers, 510 citations indexed

About

Lingfeng You is a scholar working on Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Pharmacology. According to data from OpenAlex, Lingfeng You has authored 17 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pharmacology. Recurrent topics in Lingfeng You's work include Catalytic Alkyne Reactions (7 papers), Cyclopropane Reaction Mechanisms (6 papers) and Synthetic Organic Chemistry Methods (4 papers). Lingfeng You is often cited by papers focused on Catalytic Alkyne Reactions (7 papers), Cyclopropane Reaction Mechanisms (6 papers) and Synthetic Organic Chemistry Methods (4 papers). Lingfeng You collaborates with scholars based in United States and China. Lingfeng You's co-authors include Kay M. Brummond, Richard P. Hsung, Xuejun Zhang, Yu Tang, Peter C. Sill, Hongyan Li, Zhenlei Song, Jossian Oppenheimer, Kevin P. Cole and Grant Buchanan and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

Lingfeng You

15 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingfeng You United States	10	476	71	38	32	27	17	510
Sunaina Sharma Canada	13	375 0.8×	85 1.2×	22 0.6×	22 0.7×	92 3.4×	16	452
Nobuhisa Fukuda Japan	9	513 1.1×	204 2.9×	26 0.7×	56 1.8×	74 2.7×	12	597
Milan Bergeron‐Brlek Canada	10	301 0.6×	222 3.1×	24 0.6×	18 0.6×	25 0.9×	12	355
Alan Ironmonger United Kingdom	9	437 0.9×	77 1.1×	28 0.7×	14 0.4×	115 4.3×	16	471
Wilm Buhr Germany	12	298 0.6×	121 1.7×	19 0.5×	38 1.2×	26 1.0×	15	366
Yolanda Sáinz Spain	13	490 1.0×	98 1.4×	6 0.2×	8 0.3×	20 0.7×	19	549
Alberto González Spain	14	510 1.1×	167 2.4×	21 0.6×	41 1.3×	94 3.5×	30	586
Romelo Gibe Canada	9	344 0.7×	59 0.8×	37 1.0×	114 3.6×	10 0.4×	11	412
Jean‐Charles Marié United States	9	268 0.6×	131 1.8×	29 0.8×	47 1.5×	14 0.5×	16	315
Nathan D. Ide United States	8	184 0.4×	117 1.6×	8 0.2×	12 0.4×	31 1.1×	13	256

Countries citing papers authored by Lingfeng You

Since Specialization

Citations

This map shows the geographic impact of Lingfeng You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfeng You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfeng You more than expected).

Fields of papers citing papers by Lingfeng You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfeng You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfeng You. The network helps show where Lingfeng You may publish in the future.

Co-authorship network of co-authors of Lingfeng You

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfeng You. A scholar is included among the top collaborators of Lingfeng You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfeng You. Lingfeng You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zhang, Ting, Yun Gao, Han–Wen Zheng, et al.. (2025). SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles. PLoS ONE. 20(6). e0326691–e0326691. 2 indexed citations

Yu, Xiaolan, Shuting Wang, Lingfeng You, et al.. (2025). Abstract 5460: C6P, a claudin 6 (CLDN6) directed ADC containing pyrolobenzodiazepine (PBD) for the treatment of advanced solid tumors. Cancer Research. 85(8_Supplement_1). 5460–5460.

Xu, Zhibin, Lingfeng You, Xiaoying Yang, et al.. (2024). Abstract 3145: HRA00242-C004, a novel anti-PSMA ADC with high DAR reveals potent in vitro and in vivo anti-tumor efficacy. Cancer Research. 84(6_Supplement). 3145–3145. 1 indexed citations

Xu, Zhibin, Lingfeng You, Zhe Zhang, et al.. (2024). Abstract 3146: HRA00130-C004, a novel anti-DLL3 ADC with bystander effect, high DAR and favorable safety profiles. Cancer Research. 84(6_Supplement). 3146–3146.

Zhang, Ting, Lingfeng You, Beibei Fu, et al.. (2023). Abstract LB031: SHR-A1811, a novel anti-HER2 ADC with superior bystander effect, optimal DAR and favorable safety profiles. Cancer Research. 83(8_Supplement). LB031–LB031. 15 indexed citations

Buchanan, Grant, Kevin P. Cole, Gang Li, et al.. (2011). Constructing the architecturally distinctive ABD-tricycle of phomactin A through an intramolecular oxa-[3+3] annulation strategy. Tetrahedron. 67(52). 10105–10118. 28 indexed citations

You, Lingfeng, Richard P. Hsung, Aaron A. Bedermann, et al.. (2008). An Enantioselective Synthesis of the ABD Tricycle for (−)‐Phomactin A Featuring Rawal’s Asymmetric Diels–Alder Cycloaddition. Advanced Synthesis & Catalysis. 350(18). 2885–2891. 25 indexed citations

You, Lingfeng, Z.F. Al-Rashid, Ruth Figueroa, et al.. (2007). A Two‐Carbon Homologation of Aldehydes and Ketones Using Ynamides.. ChemInform. 38(44). 2 indexed citations

Tang, Yu, Jossian Oppenheimer, Zhenlei Song, et al.. (2007). Strategies and Approaches for Constructing 1‐Oxadecalins. ChemInform. 38(6). 2 indexed citations

10.

Hsung, Richard P., Hongyan Li, Lingfeng You, et al.. (2007). Synthesis of Amide-Substituted Isoxazoles and Pyrazoles via Regioselective [3+2] Cycloadditions of Terminally Unsubstituted Ynamides. Heterocycles. 74(1). 553–553. 28 indexed citations

11.

Hsung, Richard P., Lingfeng You, Z.F. Al-Rashid, et al.. (2007). A Two-Carbon Homologation of Aldehydes and Ketones Using Ynamides. Synlett. 2007(11). 1656–1662. 9 indexed citations

12.

Zhang, Xuejun, Hongyan Li, Lingfeng You, Yu Tang, & Richard P. Hsung. (2006). Copper Salt‐Catalyzed Azide‐[3 + 2] Cycloadditions of Ynamides and Bis‐Ynamides. Advanced Synthesis & Catalysis. 348(16-17). 2437–2442. 72 indexed citations

13.

Tang, Yu, Jossian Oppenheimer, Zhenlei Song, et al.. (2006). Strategies and approaches for constructing 1-oxadecalins. Tetrahedron. 62(47). 10785–10813. 86 indexed citations

14.

Zhang, Xuejun, Richard P. Hsung, & Lingfeng You. (2006). Tandem azidination– and hydroazidination–Huisgen [3 + 2] cycloadditions of ynamides. Synthesis of chiral amide-substituted triazoles. Organic & Biomolecular Chemistry. 4(14). 2679–2682. 40 indexed citations

15.

Brummond, Kay M. & Lingfeng You. (2005). Consecutive Rh(I)-catalyzed Alder-ene/Diels–Alder/Diels–Alder reaction sequence affording rapid entry to polycyclic compounds. Tetrahedron. 61(26). 6180–6185. 44 indexed citations

16.

Brummond, Kay M., et al.. (2002). A Rhodium(I)-Catalyzed Formal Allenic Alder Ene Reaction for the Rapid and Stereoselective Assembly of Cross-Conjugated Trienes. Journal of the American Chemical Society. 124(51). 15186–15187. 147 indexed citations

17.

Zhang, Xiaosong, et al.. (1997). Ion-pair reversed-phase high-performance liquid chromatographic separation and determination of ruthenium, rhodium, cobalt and copper as chelates with 1-(2-pyridylazo)-2-naphthol-6-sulfonic acid. Journal of Chromatography A. 789(1-2). 485–489. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact